Healthcare -
Biotechnology - NASDAQ - US
$ 2.11
9.33 %
$ 45.7 M
Market Cap
-0.73
P/E
ALRN - COST OF REVENUE
Cost of Revenue ALRN - Aileron Therapeutics, Inc.
119 K
LAST VALUE
-0.83%
2 YEAR CAGR
-11.40%
5 YEAR CAGR
-37.08%
10 YEAR CAGR